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Abstract.  Myosin null mutants of Dictyostelium are 
defective for cytoldnesis, multicellular development, 
and capping of surface proteins.  We have used these 
cells as transformation recipients for an altered myosin 
heavy chain gene that encodes a protein bearing a 
carboxy-terminal 34-kD truncation.  This truncation 
eliminates threonine phosphorylation sites previously 
shown to control filament assembly in vitro.  Despite 
restoration of growth in suspension, development, and 
ability to cap cell surface proteins, these AC34-truncated 
myosin transformants display severe cytoskeletal ab- 
normalities,  including excessive localization of the 
truncated myosin to the cortical cytoskeleton, im- 
paired cell shape dynamics, and a temporal defect in 
myosin dissociation from beneath capped surface pro- 
teins. These data demonstrate that the carboxy- 
terminal domain of myosin plays a critical role in 
regulating  the disassembly of the protein from contrac- 
tile structures in vivo. 
T 
HE  production  of myosin-deficient  mutants  in Dic- 
tyosteliura by generation of antisense RNA (Knecht 
and Loomis, 1987) and by homologous recombination 
(De Lozarme and Spudich,  1987; Manstein et al., 1989) has 
provided direct genetic evidence that myosin is essential  for 
cytoldnesis and for completion ofDictyostelium's multicellu- 
lar developmental program. Studies with these mutants have 
also demonstrated that myosin is involved in movements of 
cortically linked membrane proteins,  as evidenced by the in- 
ability of myosin-deficient  cells to cap con A cross-linked 
surface proteins (Pasternak and Spudich,  1989; Fukui et al., 
1990). 
Although  a reasonably clear picture of the roles of non- 
muscle myosin is beginning to emerge, the mechanisms  con- 
trolling  assembly and localization  of myosin  structures in 
vivo are not well understood. Relocalization of myosin in re- 
sponse to cellular signals  occurs during  cytokinesis,  che- 
motaxis, and capping of surface receptors (Kitanishi-Yumura 
and Fukui,  1989; Yumura et al.,  1984; Carboni and Con- 
deelis,  1985; Schreiner  et ai.,  1977).  In all of these exam- 
ples, myosin-containing  contractile structures must be cor- 
rectly localized,  assembled, activated  for contraction,  and 
eventually  disassembled.  The feasibility  of introducing  al- 
tered myosin genes into myosin null cells now makes it possi- 
ble to identify  domains of the protein that  are critical for 
these in vivo activities. 
Several lines of evidence suggest that the myosin domains 
that  drive assembly and  regulate  assembly lie within  the 
~-helical coiled-coil tail.  Muscle myosin can be proteolyti- 
cally fragmented into heavy meromyosin (HMM)  ~  and light 
meromyosin (LMM), where the HMM fragment contains 
the globular head and the amino-terminal  third  of the tail, 
and the LMM fragment contains the carboxy-terminal  two 
thirds of the tail.  Numerous studies have demonstrated that 
the domains that drive filament assembly lie within the LMM 
portion of the molecule (Harrington and Rodgers,  1984). 
These observations have been confirmed and extended with 
Dictyostelium  myosin  HMM and LMM fragments.  When 
Dictyostelium HMM is produced in vivo in cells devoid of 
normal myosin, a diffuse distribution is observed by immuno- 
microscopy,  indicating  that the HMM molecule cannot as- 
semble into thick filaments, and is not capable of subcellular 
localization  (Fukui et al.,  1990).  Conversely,  an assembly 
domain has been identified  within  the LMM region by an 
mAb study (Pagh et al., 1984) and by recombinant genetics 
(O'HaUoran et al., 1990). A genetically engineered subfrag- 
ment located from 34 to 68 kD from the carboxy terminus 
of the tail (N34;  see Fig.  1) can assemble into LMM-type 
paracrystals.  The salt dependence of this assembly is similar 
to that of intact myosin.  Other LMM subfragments  are not 
capable of assembling,  suggesting that this domain may be 
the primary region driving assembly of the intact protein. 
The last 34 kD of the tail (C34;  see Fig.  1) may regulate 
assembly. Many cytoplasmic myosins are phosphorylated by 
heavy chain  kinases,  with consequent changes  in their as- 
1. Abbreviations used in this paper: HMM, heavy meromyosin; LMM, light 
meromyosin. 
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Figure 1.  Schematic diagram 
of Dictyostelium myosin illus- 
trating  the  positions  of pre- 
viously  identified  threonine 
phosphorylation  and  assem- 
bly domains as well as the po- 
sition of the C34 domain that 
is the focus of this study. Scale 
indicates  distance  from  the 
head- tail junction; divisions 
represent 10 nm or 8.1  kD. 
sembly properties (Collins et al., 1982; Ogihara et al., 1983; 
Cote and McCrea, 1987; Kuczmarski et al., 1987; Ravid and 
Spudich, 1989).  In Dictyostelium, phosphorylation of spe- 
cific threonines near the carboxy terminus of myosin by a 
purified myosin heavy chain kinase inhibits assembly in vitro 
at physiological salt levels. Three phosphorylatable residues 
have been identified in the C34 domain by an mAb study 
(Pagh et al., 1984) and by peptide sequencing (Vaillancourt 
et al., 1988; see Fig. 1). These three residues have been in- 
dependently identified as phosphorylation targets by expres- 
sion in E. coli  of myosin tall fragments in which individual 
threonine residues were converted to alanine or serine resi- 
dues and tested for ability to be phosphorylated by Dictyoste- 
lium kinase preparations (Luck-Vielmetter et al., 1990).  In 
vivo, myosin relocalization in response to cAMP stimulation 
has been correlated with transient heavy chain phosphoryla- 
tion, suggesting that heavy chain phosphorylation may play 
a role in the relocalization process (Berlot et al., 1987; Nach- 
mias et al.,  1989). 
To identify the in vivo roles of  this carboxy-termina134 kD 
of the myosin tail, we have transformed myosin null cells 
with an extrachromosomal vector expressing either the full- 
length myosin gene or a myosin gene bearing a truncation 
that eliminates the terminal 34 kD of the tail. This AC34 
truncation removes the sites known to undergo threonine 
phosphorylation, but leaves intact the assembly domain that 
has been identified by E. coli  expression studies (Fig. 1). The 
results reported here indicate that the carboxy-terminal do- 
main of Dictyostelium myosin is not necessary for in vivo 
contractile activity, but that it is critical for regulating the ex- 
tent of  myosin assembly in vivo and for proper control of  cor- 
ileal localization. 
Materials and Methods 
Plasmid Constructs 
The plasmid pSB2 was constructed using the ~trachromosomal hygro- 
mycin-resistance vector pDE109 (Egelhoff et al.,  1989).  pDE109 was re- 
stricted with Barn HI and Kpn I, and treated with Klenow enzyme to cre- 
ate blunt ends. A 7.7-kb Sph I-Mlu I fragment from pDE105  (Egelhoff et 
al., 1990) that contains the actin 15 promoter and the first eight codons of 
the actin 15 coding region fused to the third codon of  the myosin heavy chain 
gene was isolated, treated with Klenow enzyme to create blunt ends, and 
ligated into the pDE109 described above. The resulting plasmid pSB2 has 
the myosin and hygromycin resistance genes in a convergent orientation, 
with both genes sharing the same actin 15 terminator sequence. 
The plasmid pSB3 was constructed by replacing a 2.6-kb Kpn I-Spe I 
fragment of pSB2 with a  i.4-kb Kpn I-Spe I fragment from pMyAC34 
(O'Halloran and Spudich, 1990).  This substitution leaves the 5' end of the 
myosin construct intact, but introduces a truncation after amino acid 1,819 
of the myosin heavy chain (two extra amino acids, arginine and serina, are 
introduced after the aspartate residue at position 1,819, directly followed by 
a stop codon). 
Manipulations of Dictyostelium Cells 
Cell lines used in these studies include the Ax2 strain of Dictyostelium dis- 
coideum and a myosin null mutant, HS2206, that was generated from the 
Ax2 line by gene targeting in the manner described by Manstein et al. (1989) 
for the cell  lines mhcA-/A5-2 and mhcA-/A5-3.  These cell lines have 
been renamed HS2202 and HS2203,  respectively, using rules outlined by 
Demerec et al.,  1966. 
Cells were grown adhering to Falcon tissue culture plates containing 10 
ml of ilL5 medium (Sussman, 1987).  Growth curves in suspension culture 
were obtained by resuspending cells from plates into HL5 medium (omit- 
ting hygromycin). 10-ml  suspensions of 5  x  104 cells/ml were placed in 
50-mi flasks on a rotary platform, and cell counts were made daily using 
a hemocytometer. 
For video microscopy, cells were resuspended from plates and placed as 
hanging drops in a chamber formed by a greased rubber o-ring between a 
slide and coverslip. Samples were filmed for no more than 1-2 h before be- 
ing replaced by fresh material. Time lapse photography was carried out 
using video-enhanced  differential interference  contrast microscopy, and im- 
ages were recorded on a Panasonic optical memory laser disc. 
Transformations were done as described previously (Egelhoff et al., 
1989).  Briefly,  107  myosin null cells were electroporated with 5  /tg of 
pDEI09, pSB2, or pSB3, plated overnight in HL5, then grown in the pres- 
ence of hygromycin in 96-well microtiter plates. Cells were usually diluted 
tenfold, and 60 ~(1 were added per well of the microtiter plate in order to 
obtain approximately ten positive clones per plate and thus ensure clonality. 
Transformants were grown in 20/~g/mi hygromycin during initial character- 
ization; at later stages growth in suspension was used to select for main- 
tenance of the myosin expression plasmids. 
Electrophoretic Methods 
Southern blot analysis was performed as described by Egelhoff  et al. (1989). 
Genornic DNA samples were isolated "°4-5 wk after the transformation of 
the plasmids into the myosin null cell line. Electrophoresis conditions were 
adjusted to optimize separation of the supercoiled and nicked closed circu- 
lar plasmid DNA from the sheared chromosomal DNA. Samples were elec- 
trophoresed in a 0.6% agarose gel in TAE buffer (Maniatis et al., 1982) in 
the absence of ethidium bromide at 80 V (4.5 V/cm gel bed) for 16 h. The 
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of the myosin heavy chain (MHC) gene; (boxed arrowheads) actin 
15  promoter; (diagonal hatch boxes) actin  15  terminator; (black 
box) neomycin resistance gene; (stippled boxes) hygromycin resis- 
tance gene. The positions of sequences from Ddp2 (an endogenous 
Dictyostelium plasmid) and pUC are also indicated, pSB3 was con- 
strutted by replacing the indicated Kpn I  (K)-Spe I  (S) fragment 
of pSB2 with an analogous fragment from pMyAC34 (O'Halloran 
and Spudich, 1990) in which the myosin gene is truncated at amino 
acid  1,819 of the MHC  coding region. 
Southern filter was probed with a 3.1-kb Cla I restriction fragment of the my- 
osin gene corresponding to nucleotides  1,540-4,624  of the coding region. 
Western blot analysis was performed on whole cell lysates, which were 
prepared as described by De Lozanne and Spudich (1987). Protein was de- 
termined by the method of Peterson (1977),  and lysates were electropho- 
resed on an 8% SDS-polyacrylamide  gel (Laemmli, 1970). Western trans- 
fer was carried out as described by Towbin et al. (1979). The filter in Fig. 
3  was  probed  with a  rabbit polyclonal  antibody directed  against  Dic- 
tyostelium myosin (Berlot et al.,  1985), and the filter in Fig. 7 was probed 
with the antimyosin monoclonal My4 (Peltz et al., 1985); these primary in- 
cubations were followed  by an HRP-coupled  secondary antibody,  as de- 
scribed previously (De Lozanne and Spudich,  1987). 
For quantitation of myosin expression levels, late-log phase cell cultures 
in HL5 were harvested, washed twice in 50 mM Tris pH 7.5, then suspended 
in lysis  buffer  consisting of 50 mM Tris,  pH  8.0, 5 mM EDTA,  5 mM 
EGTA, 1% SDS, 10 ~g/ml RNase A, 0.1 mg/ml PMSF,  10 Izg/mi pepstatin, 
1 /~g/ml leupeptin, and 50 #g/ml L-l-chloro-3-[4-tosylamido]-7-amino-2- 
heptanone-HCl (TLCK).  These samples were immediately heated to 100°C 
for 10 min, then stored at -20°C. Equal amounts of total protein from each 
extract (determined with the Bio-Rad dye-binding assay) were subjected to 
SDS-PAGE. These gels were stained with Coomassie blue, destained, then 
scanned with an LKB laser densitometer to determine the amount of myosin 
in each gel lane. Scans of the entire lanes (excluding the region of the myosin 
band) were integrated and used to normalize any differences in loading be- 
tween lanes. Two adjustments were performed on the initial scans of the my- 
osin bands. First, the values  for all truncated myosin scans were divided 
by 0.86, which conv.cts for the fact that the AC34-truncated myosin is 14% 
shorter than full-length myosin. Second, two bands that comigrate with full- 
length myosin are revealed in gel lanes containing only the truncated myosin 
(these are also seen in cell extracts devoid of any myosin). Coomassie stain- 
ing due to these two bands could be determined in the truncated myosin ex- 
tracts since the truncated protein migrates at a lower position on the gels. 
The staining intensity of these bands was subtracted from the initial scan 
values for the full-length  myosin and the correct values were expressed  as 
a percent of the signal in the Ax2 wild type extract loaded on the same gel. 
Duplicate gels were run and the results were averaged and used to determine 
standard deviations. 
Capping and Immunomicroscopy 
For the time course of capping presented in Fig. 9, cells in a small drop of 
HL5  were  attached to glass coverslips  for 5 min, rinsed into starvation 
buffer (20 mM  morpholinocthanesulfonic acid (MES),  pH 6.8, 0.2 mM 
CaCI2, 2 mM MgSO4,), then incubated in 30 t~g/ml tetramethylrhodamine- 
conjugated con A (TRITC-con A; Sigma Chemical Co., St. Louis, MO) in 
starvation buffer for 1 min. Excess con A was removed by rinsing attached 
cells briefly in starvation  buffer. Cells were fixed at the indicated time points 
with 2 % formalin in starvation buffer for 10 rain. Coverslips  were rinsed 
and mounted in glycerol  for fluorescence  microscopy. 
For the experiments colocalizing myosin with caps,  cells were treated 
with con A as described above.  After rinsing back into starvation buffer, 
cells were overlaid with a thin agar sheet until the time of fixation. This agar 
overlay technique generally improves  preservation of small cells such as 
Dicryostelium  (Fukui et al., 1987). We found that the application of the agar 
sheet improved the synchrony of capping,  and had no adverse effect on the 
rate of capping.  The agar sheet also improved retention of the cells to the 
glass coverslip during fixation. At the indicated time points, cells were fixed 
in 1% formalin in acetone at -10oc for 5 rain. Coverslips  were rinsed in 
PBS before proceeding to antibody incubations.  Other details of the immu- 
nomicroscopy  were done as previously  described for the agar overlay tech- 
nique (Fukui et al., 1987), with minor modifications that we have described 
previously (Egelhoffet al., 1990). Primary and secondary antibody incuba- 
tions were clone in PBS containing 1% BSA at 37°C for 30 rain, each fol- 
lowed by three rinses in PBS. A rabbit  polyclonal antiserum directed against 
Dictyostelium  myosin was used at a 1:300 dilution, followed by fluorescein- 
conjugated,  afffinity-purified goat anti-rabbit IgG (Cappell),  used at a 1:30 
dilution. 
Isolation of Triton-insoluble Cytoskeletons 
Triton-insoluble cytoskeletons  and Triton-soluble fractions of cells were 
isolated as described previously  (Spudich,  1987),  with modifications  de- 
scribed below.  1.5  x  10  ~ cells from log phase cultures were washed twice 
in 10 mM Tris, pH 7.5, 100 mM KCI, then resuspended in 150 ~l of 0.1 M 
MES,  pH 6.8, 2.5 mM EGTA,  5 mM MgCl2,  and 0.5 mM ATP at 0°C. 
An equal volume of the same buffer containing 1% Triton X-100, 0.1 mg/ml 
PMSF,  10 izg/ml leupeptin,  50 t~g/ml TLCK, and 10 ~g/ml pepstatin was 
added, and the suspension vortexed  for 5 s at medium setting.  The lysed 
mixture was then centrifuged for 1 min in a microfuge. The Triton-insoluble 
pellet was dissolved  in SDS gel  sample buffer and heated to  100°C  for 
5 min. The Triton-soluble  supernatant  was precipitated  by addition  of  700 izl 
of acetone and incubation on ice (10 vain), then pelleted and resuspended 
in SDS gel sample buffer as above. SDS-PAGE was performed, and the re- 
Figure 3. Western blot analysis. 5/zg of total protein from different 
cell lines is loaded in lanes a-i. (lane a) Ax2; (lane b) myosin null 
cell  line HS2206  transformed with  the  vector alone  (pDE109); 
(lanes c-e) HS2206 cells transformed with pSB2 expressing full- 
length myosin; (lanes  f-i) HS2206 cells transformed with pSB3 ex- 
pressing the truncated myosin.  The solid arrowhead indicates the 
position of full length myosin (240 kD),  and the open arrowhead 
indicates the position of the truncated myosin (205 kD). 
Egelhoff  et al. Control of  Myosin Disassembly In Vivo  679 alone is shown in lane b. Three cell lines with the full-length 
myosin introduced (lanes c-e) all express myosin at levels 
roughly similar to wild type cells, and four cell lines with 
the AC34-truncated myosin (lanes f-i)  introduced all ex- 
pressed the protein at levels somewhat lower than wild type 
cells. After initial characterization, one full-length and one 
truncated myosin cell line were chosen for further studies. 
Densitometer scans of the myosin bands in SDS-polyacryl- 
amide gels of cell extracts of these cell lines revealed that ex- 
pression in the full-length myosin transformants was 91% 
(+18; n  =  6) of the wild type level, and expression in the 
AC34-truncated myosin transformants was 42% (+8; n =  6) 
of the wild type level. 
Southern blot analysis of these transformants confirmed 
that pSB2 and pSB3 were present and appear to be main- 
tained  extrachromosomally (Fig.  4).  DNA  isolated  from 
three pSB2 transformants (Fig. 4, lanes e-g) demonstrated 
that much of the plasmid migrates at the position of super- 
coiled or nicked circular plasmid.  Some plasmid also mi- 
grates at the position of the sheared chromosomal DNA. A 
similar pattern is seen for the pSB3 transformants (Fig. 4, 
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Figure 4.  Southern blot analysis. Undigested total DNA samples 
were electrophoresed on an agarose gel to resolve circular  and 
sheared linear DNA. The arrow at the right margin indicates the 
position of migration of the linear sheared chromosomal DNA. At 
the left margin, filled arrowheads indicate the position of migration 
of pSB2 in nicked circular  form (upper) and supercoiled form 
(lower); the open arrowheads indicate the position of migration 
of pSB3 in nicked circular  form (upper) and supercoiled form 
(lower). (lane a) Purified pSB2 DNA; (lane b) purified pSB3 DNA; 
(lane c) Ax2 wild type DNA;  (lane d) HS2206 null cell DNA; 
(lanes e-g) DNA from null cells transformed with pSB2; (lanes 
h-k) DNA from null cells transformed with pSB3. 
solved proteins were either transferred to nitrocellulose filters for Western 
blot analysis as described above, or stained with Coomassie blue. 
Results 
Transformation of the myosin null cell line HS2206 with the 
plasmids pSB2 or pSB3 (Fig. 2) resulted in cells that express 
full-length  or  truncated  myosin,  respectively,  as  seen by 
Western blot analysis (Fig.  3). The expression level of the 
original Ax2 cells is shown in lane a, and the absence of my- 
osin expression in myosin null cells transformed with vector 
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Figure 5. Growth curves. On day 0, parallel aliquots of cells grow- 
ing on plates were placed into suspension culture or prepared for 
the western blots shown in Fig. 3. Cells are wild type Ax2 (open 
diamonds), HS2206 myosin null cells (fiUeddiamonds), three pSB2 
transformants of HS2206 (filled triangles and filled circles), four 
pSB3 transformants of HS2206 (open triangles, open circles, and 
open squares),  and HS2206 null cells transformed with vector 
alone (filled squares). 
The Journal of Cell Biology, Volume 112,  1991  680 Figure 6. Video microscopy of cells in suspension. A-C show HS2206 cells transformed with pSB2 at three consecutive l-rain intervals. 
D-F show HS2206 cells transformed with pSB3 at three consecutive l-rain intervals. The stiff, multilobed appearance of  the AC34-truncated 
myosin cells is apparent in D-E 
lanes h-k).  The resolution of high molecular weight linear 
DNA with these electrophoresis conditions is such that the 
sheared chromosomal DNA often runs at a position similar 
to size standards in the 20-kb range; we are not certain there- 
fore whether the myosin homology migrating at the position 
of  the chromosomal DNA represents integrated plasmid cop- 
ies or sheared plasmids that are comigrating with the chro- 
mosomal material.  It is  clear,  however,  that a  substantial 
portion of the introduced plasmid DNA has remained extra- 
chromosomal. 
Egelhoff et al.  Control of Myosin Disassembly In Vivo  681 Figure  7.  SDS-PAGE of Triton-insoluble cytoskeleton fractions 
and Triton-soluble fractions. Triton-soluble and Triton-insoluble 
fractions of cell lysates were subjected to SDS-PAGE and stained 
with Coomassie blue (lanes 1-6). A duplicate gel was blotted to 
a nitrocellulose filter and probed with an mAb specific to Dic- 
tyostelium  myosin (lanes 7-12).  Odd-numbered lanes contain 
Triton-insoluble  fractions and even-numbered  lanes contain Triton- 
soluble fractions. (lanes 1, 2,  7, and 8) Wild type Ax2 fractions; 
(lanes 3, 4, 9, and 10) full-length myosin transformant fractions; 
(lanes 5, 6, 11, and 12) AC34-truncated myosin transformant frac- 
tions. The solid arrowhead to left indicates position of wild type 
and full-length myosin; the open arrowhead indicates the position 
of the AC34-truncated myosin. 
To assay competence for cytokinesis, we placed the full- 
length and AC34-truncated myosin transformants in suspen- 
sion culture and monitored growth.  Wild type Ax2 cells 
grow in suspension with a doubling time of ~8-10 h (Fig. 
5, open diamonds).  Myosin null cells are unable to grow in 
suspension due to their defect in cytokinesis (Fig. 5, filled 
diamonds);  these null cells become large and multinucleated 
and eventually lyse. In this assay, full-length myosin transfor- 
mants grew at rates very similar to the Ax2 wild type cells 
(Fig.  5, filled circles  and filled triangles),  and the AC34- 
truncated myosin transformants grew at rates only slightly 
slower than the wild type Ax2 cells (Fig. 5, open triangles, 
squares,  and circles). 
Video microscopy was performed to examine the behavior 
of the AC34-truncated myosin transformants in suspension. 
Transformants containing full-length myosin behaved like 
wild type cells, in that they appeared generally round and ac- 
tively extended and retracted projections (pseudopodia and 
filopodia) of the cell surface (Fig. 6, A-C).  Transformants 
containing the truncated myosin underwent dramatic rapid 
deformations from a  round shape,  often appearing multi- 
lobed, with rigid lobes persisting several minutes or longer 
before being reabsorbed (Fig. 6, D-F).  Extensions and re- 
tractions of pseudopodia and filopodia were not obvious in 
the truncated myosin cells; the deformations in shape and 
formation of stiff  lobes may represent attempts to form pseu- 
dopodia, but these structures are very different in appear- 
ance and in dynamics from the pseudopodia of the control 
cells or wild type cells. 
The AC34-truncated myosin transformants, while capable 
of growing in suspension, form multinucleated cells, which 
indicates abnormalities in the cell division process. In three 
cases where cell division events were observed in suspension 
by differential interference contrast microscopy, the cells 
showed multiple furrows and ultimately divided into an un- 
even number of daughter cells that varied by as much as two- 
fold in size from one another. In contrast, several division 
events observed in the full-length myosin transformants all 
resulted in two daughter cells of equal size.  These observa- 
tions suggest that the AC34-truncated myosin is capable of 
driving cytokinesis, but does so in an imperfect manner. 
We also examined the ability of the transformants to de- 
velop. When cells taken from suspension culture were plated 
on MES starvation plates (Sussman, 1987), both full-length 
and AC34-truncated myosin transformants were able to com- 
plete development, forming fruiting bodies and producing 
spores (data not shown). 
As an initial test of the in vivo assembly properties of 
the  truncated  myosin we prepared  actin-enriched Triton- 
insoluble cytoskeletons by lysis of cells in the presence of 
EGTA and Triton X-100  (Spudich,  1987).  Comparison of 
these Triton-insoluble cytoskeletons with the Triton-soluble 
fractions  resolved  on  SDS-polyacrylamide gels  revealed 
defective myosin localization in the truncated myosin trans- 
formants (Fig. 7). Myosin in wild type cells and in the full- 
length myosin transformants fractionates primarily in the 
Triton-soluble fraction (Fig. 7, lanes 2, 4, & and 10), while 
the majority of the AC34-truncated myosin fractionates with 
the Triton-insoluble cytoskeleton (Fig. 7,  lanes 5  and 1/). 
Densitometric scans of a typical fractionation indicated that 
13% of wild type myosin and 13% of the full-length myosin 
fractionated with the Triton-insoluble cytoskeleton in Ax2 
cells  and  full-length myosin  transformants,  respectively. 
In contrast,  in the  Ae34-truncated myosin transformants, 
80%  of the myosin fractionated with the Triton-insoluble 
cytoskeletons. 
Immunomicroscopy was  performed to  examine myosin 
distribution.  Staining of full-length myosin transformants 
with an antimyosin  antiserum revealed a myosin distribution 
that was indistinguishable from that of the wild type Ax2 
cells. In these cells the myosin is evenly distributed through- 
out the cortex of the cell as a loose fibrous network (Fig. 8, 
A-C). In contrast, myosin distribution in the truncated myo- 
sin transformants is highly abnormal. The majority of these 
cells contain dense cortical patches of myosin that are not 
evenly dispersed.  These patches vary considerably in size 
between cells, but usually occupy only a fraction of the cell 
cortex, with the remainder of the cortex being relatively de- 
void of myosin staining (Fig. 8, D-F). Through-focusing on 
these cells indicated clearly that these arrays of myosin were 
in the cortices of the fixed cells and not in the endoplasm. 
Control staining of  these cells with secondary antibody alone 
resulted  in  extremely faint diffuse fluorescence.  Further- 
more, staining of the myosin null cell line HS2206 with the 
antimyosin antiserum and secondary antibody also resulted 
in extremely faint diffuse fluorescence, confirming the speci- 
ficity of the immunostaining (data not shown). 
As a further assay of in vivo myosin function, we tested 
the ability of these cells to cap cell surface glycoproteins in 
The Journal of Cell Biology, Volume t 12;  1991  682 Figure 8. Immunolocalization  of myosin. A-C show FITC antimyosin staining of HS2206 null cells transformed with pSB2, expressing 
full-length myosin. D-F show FITC antimyosin staining of HS2206 null ceils transformed with pSB3, expressing the AC34-truncated 
myosin. 
response to treatment with con A.  When full-length and 
truncated myosin  transformants  were treated with rhodamine- 
labeled con A (TRITC-con A), both cell types formed dis- 
crete polar aggregations of con A with similar kinetics (Fig. 
9).  The intensity and uniformity of capping by full-length 
myosin transformants (Fig. 9, middle row) was indistinguish- 
able from wild type Ax2 cells (not shown). The degree of 
capping induced in the truncated myosin transformants (Fig. 
9, bottom row) was similar to that of full-length  myosin trans- 
formants. Myosin null cells showed no capping response at 
all (Fig. 9, top row); at later time points patching became ap- 
parent on the null cells, and more brightly staining areas 
were seen that represent endocytosed material accumulating 
within the  cells  (apparent by  focusing through  the  fixed 
cells). 
It has been shown previously that myosin colocalizes with 
cap structures as they are forming in Dictyostelium, but that 
the myosin delocalizes from beneath the cap once the cap has 
formed (Carboni and Condeelis, 1985). These steps are then 
followed by gradual endocytosis of the capped surface pro- 
teins.  We  used  this  process  as  an  assay to  examine the 
recruitment and delocalization competence of the AC34- 
truncated myosin. Cells were treated briefly with con A, al- 
lowed to cap for either 4 or 30 min, and then fixed. These 
cells were then fluorescently stained for myosin. Full-length 
myosin transformants displayed a high frequency of myosin 
colocalization with caps when fixed at 4 min (Fig. 10, A-C), 
and almost never displayed myosin colocalized with the caps 
when fixed at 30 min (Fig.  10, D-F), consistent with the 
previously published behavior of wild type Dictyostelium 
Egelhoff  et al. Control of Myosin Disassembly In Vivo  683 Figure 9. Con A-induced capping in transformants. Cells were attached to glass coverslips, treated with 30/zg/ml rhodamine-conjugated 
con A (TRITC-con A), and fixed at 1, 5, 10, and 20 min, as indicated at the top of  the figure. (a-d) HS2206 null cells; (e-h) pSB2 (full-length 
myosin) transformants of HS2206 null cells; (i-l) pSB3 (truncated myosin) transformants of HS2206 null cells. 
(Carboni and Condeelis,  1985). When fixed at 4  min, the 
AC34-truncated myosin transformants also displayed a high 
frequency of colocalization with caps (Fig. 10, G-I). In con- 
trast to the full-length myosin transformants, however, these 
cells continued to display high frequencies of myosin colo- 
calization with the caps at 30 min (Fig.  10, J-L), as well as 
at 60 min (data not shown). Although the truncated myosin 
at 30 min colocalized with high frequency, it consistently had 
a less compact appearance than at 4 min, with the periphery 
of the patch of myosin usually extending beyond the edges 
of the surface protein cap. This point is apparent by compar- 
ing Fig.  10, H  and I to Fig.  10, K and L. 
The frequency of myosin coloealization was  scored for 
>200 cells for each of the time points above (Fig. 11). At the 
4-min time point, both full-length and truncated myosin dis- 
played high frequencies of colocalization with caps (72 and 
99 %, respectively). The coloealization of  the truncated myo- 
sin was consistently more frequent and more intense than 
that of full-length myosin at this time point. At 30 min 95 % 
of the truncated myosin transformants showed myosin colo- 
calized with the con A caps, while only 4 % of the full-length 
myosin transformants showed detectable colocalization. En- 
docytosis of the capped surface proteins did not appear to be 
severely impaired in the truncated myosin transformants; at 
30 min both cell types showed roughly similar amounts of 
fluorescent cytoplasmic vesicles resulting from endocytosis. 
Discussion 
The results reported here demonstrate that the carboxy-ter- 
Figure 10. Association of myosin with con A-induced caps. Ceils were attached to coverslips and induced to form surface protein caps 
with TRITC-con A as described under Materials and Methods. These  cells were then fixed  at 4 or 30 rain after con A exposure and processed 
for immunofluorescent  myosin staining, using an antimyosin antiserum and FITC-labeled secondary antibody. The left column shows phase- 
contrast images, the center eolurnn shows TRITC-labeled con A caps, and the right column shows FITC-antimyosin staining. A-C show 
full-length myosin transformants at 4 min; D-F show full-length myosin transformants at 30 min; G-I show AC34-truncated myosin trans- 
formants at 4 min; J-L show AC34-truncated myosin transformants at 30 rain. Bar,  10 ftm. 
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length  and  AC34-truncated  myosin  transformants.  Cells  were 
treated as for Fig. 10 and scored for whether myosin showed  distinct 
enrichment in the cortex of the cell underlying the cap structure. 
Greater than 200 cells were scored at each time point. Cells were 
scored as showing colocalization of myosin with the cap if the most 
intense area of myosin staining coincided with the location of the 
cap; in many cases a gradient of myosin staining intensity was ob- 
served (especially with full-length myosin at the 4-min point). Cells 
were chosen for scoring while observing the TRITC fluorescence 
channel (to monitor TRITC-con A), so that only cells that displayed 
capped surface protein were selected. For both cell types at the 30- 
min time point "~25-50% of the cells no longer had a clear single 
cap of fluorescent con A, and these cells were not included in the 
cell scoring. 
mina134-kD of  the Dictyostelium myosin tail plays a key role 
in allowing the cell to disassemble myosin from contractile 
structures. The in vivo properties of  the AC34-truncated my- 
osin provide support for earlier studies with purified myosin 
that have implicated the carboxy terminus in control of as- 
sembly (Pagh et al.,  1984; Kuczmarski et al.,  1987;  Ravid 
and  Spudich,  1989;  Vaillancourt et al.,  1988).  Based on 
those biochemical studies, we predicted that a AC34-trun- 
cated myosin would be relatively normal for recruitment to 
contractile structures and for contraction itself, but that dis- 
assembly of  this protein from contractile structures would be 
impaired. Our results bear out this interpretation. 
The strongest evidence that this domain is required for dis- 
assembly comes from the capping experiments. The kinetics 
of cap  formation in  the AC34-truncated myosin transfor- 
mants is indistinguishable from the wild type or full-length 
myosin transformants, and the kinetics of colocaiization of 
the truncated protein to the cap are similar as well. Unlike 
the full-length myosin, however, the truncated myosin re- 
mained highly colocalized with the caps for up to 60 min af- 
ter initiation of capping.  It is  interesting that even at the 
4-rain time point, the truncated myosin consistently showed 
stronger colocalization with the forming cap of surface pro- 
teins. This result is consistent with a capping model in which 
myosin is responsible for sweeping patched surface proteins 
into the forming cap, and that once at the cap, myosin nor- 
mally disassembles and cycles back into the cytoplasm. In 
the truncated myosin transformants an apparent defect in the 
disassembly step results in excessive colocalization of the 
truncated myosin even at the early stages of the process. The 
less compact appearance of  the colocalized truncated myosin 
at 30 min may reflect a relaxation that occurs after capping 
is  complete and  the  contractile activity of the  myosin is 
turned off (Bourguignon and Bourguignon,  1984). 
Our  working  model  for how  the  cell  controls  myosin 
relocalization is based on the idea that in a resting state the 
majority of the cellular myosin is monomeric and located in 
the cytoplasm.  Upon stimulus for a contractile event, de- 
phosphorylation of the  heavy chains  of these  monomers 
leads to filament formation, concurrent  with light chain phos- 
phorylation that activates the contractile activity of the myo- 
sin. Myosin filaments would associate with the cortical cyto- 
skeleton due in part to the increased affinity of the filaments 
relative to monomers for actin;  recruitment to the cortex 
might also be stimulated by light chain phosphorylation or 
effects  of  other components of  the cytoskeleton. Cortical ilia- 
merits  are presumed to be the active contractile form used 
by the cell; recruitment of filaments to specific regions of  the 
cortex may occur by "cortical sliding," as discussed below, 
but other mechanisms that directly limit assembly to certain 
zones (e.g., the contractile ring in the furrow region) are not 
ruled out.  Upon termination of a contractile event, myosin 
heavy chain phosphorylation and light chain dephosphoryla- 
tion would occur, disassembling the cortical filaments, inac- 
tivating the actin-activated ATPase and contractile activity, 
and allowing monomers to redistribute to the cytoplasm. 
One implication of this model is that rapid dephosphoryla- 
tion  of  cytoplasmic  myosin  must  occur  in  response  to 
recruitment signals;  very little is known in regard to this 
point. The other components of the model are all consistent 
with current information regarding the biochemical proper- 
ties of myosin and the in vivo properties presented in this 
work. In this model, the equilibrium between monomers and 
filaments would be shifted greatly towards filaments for the 
AC34-truncated myosin; this shift could be sufficient to con- 
fer cortical localization due to increased actin affinity, even 
in the absence of light chain phosphorylation. Because the 
AC34-truncated myosin heavy chains are not phosphorylata- 
ble at the end of a contractile event, the protein remains as- 
sembled in the cortex of the cell; the relaxation or spreading 
out of this material that is apparent after completion of cap- 
ping (Fig.  10 L) may reflect the gradual diffusion of these 
filaments into the rest of  the cortex once contraction is termi- 
nated. Clearly much work remains to be done to determine 
whether this model is correct and sufficient to explain myo- 
sin localization control. 
Impaired disassembly of the cortical myosin in the AC34- 
truncated myosin cells might also explain their stiff appear- 
ance and lack of normal pseudopod dynamics. If pseudopod 
extension requires localized disassembly and rearrangement 
of the cortical cytoskeleton at a specific site, then the trun- 
cated myosin assembled into the cortex at such a spot would 
probably not disassemble properly, and might inhibit other 
events that would normally drive pseudopod extension. 
The behavior of  the truncated myosin transformants during 
capping also offers a  possible explanation for the cortical 
patches of assembled myosin that were observed in cells that 
were not treated with con A. It is conceivable that the corti- 
cal aggregates of myosin filaments seen in the truncated myo- 
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previous division attempts. The myosin in these cells may be 
capable of correct recruitment to the contractile ring during 
cell division, but subsequently unable to disassemble. Steric 
hindrance of furrowing by this myosin that is impaired for 
disassembly might explain the aberrant  divisions observed 
by video microscopy, as well as the slightly slower growth 
rate of these cells in suspension culture. We cannot exclude 
the possibility that these defects are the result of the reduced 
expression  level of the truncated  myosin (42% relative to 
myosin expression in wild type cells). 
The fact that the AC34-truncated myosin transformants do 
seem to initiate cytokinesis suggests that the truncated myo- 
sin in these cells may be recruited to the forming cleavage 
furrow by cortical  sliding rather  than by disassembly  and 
subsequent reassembly from the endoplasm. Recruitment of 
this myosin to the cleavage furrow via cortical sliding would 
support recently proposed models for contractile ring assem- 
bly (Bray and White,  1988), and would be consistent with 
the recent demonstration that F-actin can be recruited to the 
cleavage furrow without disassembly into monomers (Cao 
and Wang, 1990). 
Cote  and  McCrea  (1987) have performed  biochemical 
analysis on a truncated Dictyostelium myosin very similar to 
the molecule that we have analyzed in vivo in this study. They 
used chymotryptic  cleavage to remove a carboxy-terminal 
fragment  of 33,700 D from the tail of the molecule,  and 
demonstrated that the cleavage site was just after the tyrosine 
at position 1,825 of myosin. This site is only six amino acids 
past the position of  the truncation we report here, so that one 
might expect these two myosins to have similar properties. 
The salt dependence of assembly of  their chymotryptic myo- 
sin was generally similar to wild type unphosphorylated my- 
osin, consistent with the idea that the domain that drives as- 
sembly lies amino-terminal  to the truncation  ("N34"; see 
Fig.  1), and consistent with the data presented here which 
indicates that the AC34-truncated myosin assembles in vivo. 
In preliminary  biochemical  studies,  we find that purified 
AC34-truncated myosin also has a salt dependence of  assem- 
bly that is similar  to wild type unphosphorylated  myosin 
(data not shown). One particularly  interesting result from 
the Cote and McCrea work was that their chymotryptic myo- 
sin displayed only 20 % of the wild type actin-activated ATP- 
ase. It will be of interest to determine whether the in vitro 
actin-activated ATPase of  our AC34-truncated myosin is also 
reduced;  the competence of AC34-truncated myosin for in 
vivo.contractile processes would imply that the in vivo actin- 
activated ATPase of  this molecule should not be substantially 
impaired.  Such a discrepancy between in vivo and in vitro 
properties could conceivably reflect differences in structure 
between filaments formed in vivo and filaments formed in 
vitro. 
O'HaUoran and Spudich (1990) recently used a different 
method, based on homologous recombination, to generate a 
Dictyostelium cell line that produced a similar truncated my- 
osin protein. Although their study did not address the cellu- 
lar dynamics of the altered myosin, the resultant cell line, 
unlike the AC34-truncated transformants of our study,  was 
unable to grow in suspension. We have determined that the 
expression level of the truncated protein in their cell line is 
13% of wild type (SD =  3.7; n = 6), using the same quanti- 
tation method presented above for our cell lines. The low ex- 
pression level in their cells probably accounts for the block 
they observed in cell division. 
The results presented here demonstrate that the carboxy- 
terminal domain of Dictyostelium myosin plays a critical role 
in the regulation of myosin assembly into the cytoskeleton, 
and suggest that this domain may specifically mediate disas- 
sembly of myosin from the cytoskeleton after completion of 
a contractile  event.  Further analysis with other  truncated 
myosin genes and with site-directed alterations of  the myosin 
gene will allow precise identification of the critical residues 
in this domain. With these approaches it will be possible to 
determine whether it is the phosphorylation sites previously 
identified in vitro or other sequences within this domain that 
regulate the assembly state of the myosin molecule. 
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